Otezla (apremilast) — Point32Health

Initial criteria

• Documented diagnosis of plaque psoriasis
• Patient age ≥ 6 years AND weight ≥ 20 kg
• Prescribed by or in consultation with a dermatologist
• One of the following: inadequate response to one of the following topical therapies (a corticosteroid, a vitamin D analog, tazarotene, calcineurin inhibitor, anthralin, or coal tar) OR contraindication to all of the following topical therapies (corticosteroids, vitamin D analogs, tazarotene, calcineurin inhibitors, anthralin, and coal tar) OR previous treatment with a biologic agent indicated for the requested use OR patient is new to the plan and has been stable on the requested agent prior to enrollment